Noevir Holdings Co Ltd
TSE:4928
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Noevir Holdings Co Ltd
Other Assets
Noevir Holdings Co Ltd
Other Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Noevir Holdings Co Ltd
TSE:4928
|
Other Assets
¥116m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-1%
|
|
|
Shiseido Co Ltd
TSE:4911
|
Other Assets
¥58.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Other Assets
¥33B
|
CAGR 3-Years
132%
|
CAGR 5-Years
62%
|
CAGR 10-Years
41%
|
|
|
Kao Corp
TSE:4452
|
Other Assets
¥231.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
F
|
Fancl Corp
TSE:4921
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Other Assets
¥7.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
Noevir Holdings Co Ltd
Glance View
In the versatile world of beauty and wellness, Noevir Holdings Co Ltd. stands as a testament to astute innovation combined with a well-honed business acumen. Founded in Japan, this company has expertly navigated the delicate balance of tradition and modernity to emerge as a prominent figure in the skincare and cosmetic industries. Noevir's strategy is rooted in the meticulous formulation of its products, drawing inspiration from natural ingredients, which reflects the company’s keen attention to quality and detail. By leveraging advanced research and development techniques, Noevir crafts a diverse range of skincare and personal care products designed to cater to the discerning needs of its clientele. They operate primarily through direct sales channels, allowing them to maintain a personal relationship with their customers, understanding their preferences deeply and ensuring a consistent brand experience. Financially, Noevir Holdings generates revenue by employing a multi-faceted business model, anchoring itself in both domestic and international markets. Besides its leading role in the cosmetics sector, the company diversifies through its involvement in pharmaceuticals and health foods, broadening its portfolio to mitigate market risks. This diversity not only stabilizes the company’s revenue streams but also aligns with the increasing consumer emphasis on holistic health and wellness solutions. Noevir's ability to anticipate and respond to market trends ensures its growth trajectory, having firmly established its brand in the Asian market while progressively expanding its footprint across regions. As a result, the company's strategy encompasses not just product innovation but also a robust marketing and distribution network that reinforces its position as a leader in the beauty and wellness industry.
See Also
What is Noevir Holdings Co Ltd's Other Assets?
Other Assets
116m
JPY
Based on the financial report for Dec 31, 2025, Noevir Holdings Co Ltd's Other Assets amounts to 116m JPY.
What is Noevir Holdings Co Ltd's Other Assets growth rate?
Other Assets CAGR 10Y
-1%
Over the last year, the Other Assets growth was -23%. The average annual Other Assets growth rates for Noevir Holdings Co Ltd have been -17% over the past three years , -15% over the past five years , and -1% over the past ten years .